Suppr超能文献

减毒天花疫苗LC16m8在免疫缺陷小鼠中的安全性

Safety of attenuated smallpox vaccine LC16m8 in immunodeficient mice.

作者信息

Yokote Hiroyuki, Shinmura Yasuhiko, Kanehara Tomomi, Maruno Shinichi, Kuranaga Masahiko, Matsui Hajime, Hashizume So

机构信息

The Chemo-Sero-Therapeutic Research Institute (Kaketsuken), Okubo, Kita-ku Kumamoto-shi, Kumamoto, Japan

The Chemo-Sero-Therapeutic Research Institute (Kaketsuken), Okubo, Kita-ku Kumamoto-shi, Kumamoto, Japan.

出版信息

Clin Vaccine Immunol. 2014 Sep;21(9):1261-6. doi: 10.1128/CVI.00199-14. Epub 2014 Jul 2.

DOI:10.1128/CVI.00199-14
PMID:24990910
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4178579/
Abstract

Freeze-dried live attenuated smallpox vaccine LC16m8 prepared in cell culture has been the sole smallpox vaccine licensed in Japan since 1975 and was recently recommended as a WHO stockpile vaccine. We evaluated the safety of recently remanufactured lots of LC16m8 using a series of immunodeficient mouse models. These models included suckling mice, severe combined immunodeficiency disease (SCID) mice, and wild-type mice treated with cyclosporine. LC16m8 showed extremely low virulence in each of the three mouse models compared with that of its parental strains, Lister and LC16mO. These results provide further evidence that LC16m8 is one of the safest replication-competent smallpox vaccines in the world and may be considered for use in immunodeficient patients.

摘要

自1975年以来，在细胞培养中制备的冻干减毒活天花疫苗LC16m8一直是日本唯一获得许可的天花疫苗，最近被推荐作为世界卫生组织的储备疫苗。我们使用一系列免疫缺陷小鼠模型评估了最近重新生产的批次的LC16m8的安全性。这些模型包括乳鼠、严重联合免疫缺陷病（SCID）小鼠和用环孢素处理的野生型小鼠。与亲代菌株李斯特菌和LC16mO相比，LC16m8在三种小鼠模型中的毒力极低。这些结果进一步证明LC16m8是世界上最安全的具有复制能力的天花疫苗之一，可考虑用于免疫缺陷患者。

相似文献

1
Safety of attenuated smallpox vaccine LC16m8 in immunodeficient mice.
Clin Vaccine Immunol. 2014 Sep;21(9):1261-6. doi: 10.1128/CVI.00199-14. Epub 2014 Jul 2.
2
Vaccinia virus strain LC16m8 defective in the B5R gene keeps strong protection comparable to its parental strain Lister in immunodeficient mice.
Vaccine. 2015 Nov 9;33(45):6112-9. doi: 10.1016/j.vaccine.2015.07.076. Epub 2015 Aug 1.
3
Recent advances in the study of live attenuated cell-cultured smallpox vaccine LC16m8.
Vaccine. 2015 Nov 9;33(45):6106-11. doi: 10.1016/j.vaccine.2015.07.111. Epub 2015 Aug 28.
4
Freeze-dried live attenuated smallpox vaccine prepared in cell culture "LC16-KAKETSUKEN": Post-marketing surveillance study on safety and efficacy compliant with Good Clinical Practice.
Vaccine. 2015 Nov 9;33(45):6120-7. doi: 10.1016/j.vaccine.2015.09.067. Epub 2015 Oct 9.
5
Safety and immunogenicity of LC16m8, an attenuated smallpox vaccine in vaccinia-naive adults.
J Infect Dis. 2011 Nov;204(9):1395-402. doi: 10.1093/infdis/jir527. Epub 2011 Sep 15.
6
Genetically stable and fully effective smallpox vaccine strain constructed from highly attenuated vaccinia LC16m8.
Proc Natl Acad Sci U S A. 2005 Mar 15;102(11):4152-7. doi: 10.1073/pnas.0406671102. Epub 2005 Mar 7.
7
LC16m8: an attenuated smallpox vaccine.
Vaccine. 2006 Nov 17;24(47-48):7009-22. doi: 10.1016/j.vaccine.2006.03.087. Epub 2006 Apr 21.
8
Clinical and immunological response to attenuated tissue-cultured smallpox vaccine LC16m8.
JAMA. 2009 Mar 11;301(10):1025-33. doi: 10.1001/jama.2009.289.
9
An attenuated LC16m8 smallpox vaccine: analysis of full-genome sequence and induction of immune protection.
J Virol. 2005 Sep;79(18):11873-91. doi: 10.1128/JVI.79.18.11873-11891.2005.
10
A Single Vaccination of Nonhuman Primates with Highly Attenuated Smallpox Vaccine, LC16m8, Provides Long-term Protection against Monkeypox.
Jpn J Infect Dis. 2017 Jul 24;70(4):408-415. doi: 10.7883/yoken.JJID.2016.417. Epub 2016 Dec 22.

引用本文的文献

1
Development of a Broad-Spectrum Pan-Mpox Vaccine via Immunoinformatic Approaches.
Int J Mol Sci. 2025 Jul 25;26(15):7210. doi: 10.3390/ijms26157210.
2
An open-label, non-randomized study investigating the safety and efficacy of smallpox vaccine, LC16, as post-exposure prophylaxis for mpox.
Hum Vaccin Immunother. 2023 Aug 1;19(2):2242219. doi: 10.1080/21645515.2023.2242219.
3
Monkeypox: Clinical Issues of Concern.
J Transl Int Med. 2023 Jan 13;10(4):297-299. doi: 10.2478/jtim-2022-0038. eCollection 2022 Dec.
4
Monkeypox (Mpox) vaccines and their side effects: the other side of the coin.
Int J Surg. 2023 Feb 1;109(2):215-217. doi: 10.1097/JS9.0000000000000142.
5
Advances in Next-Generation Coronavirus Vaccines in Response to Future Virus Evolution.
Vaccines (Basel). 2022 Nov 29;10(12):2035. doi: 10.3390/vaccines10122035.
6
Immunoinformatics-Aided Design of a Peptide Based Multiepitope Vaccine Targeting Glycoproteins and Membrane Proteins against Monkeypox Virus.
Viruses. 2022 Oct 27;14(11):2374. doi: 10.3390/v14112374.
7
Monkeypox: epidemiology, pathogenesis, treatment and prevention.
Signal Transduct Target Ther. 2022 Nov 2;7(1):373. doi: 10.1038/s41392-022-01215-4.
8
Vaccinia Virus Expressing Interferon Regulatory Factor 3 Induces Higher Protective Immune Responses against Lethal Poxvirus Challenge in Atopic Organism.
Viruses. 2021 Oct 3;13(10):1986. doi: 10.3390/v13101986.
9
A Critical Analysis of the Scientific and Commercial Rationales for the Synthesis of Horsepox Virus.
mSphere. 2018 Mar 7;3(2). doi: 10.1128/mSphere.00040-18. eCollection 2018 Mar-Apr.
10
Construction and characterization of bacterial artificial chromosomes harboring the full-length genome of a highly attenuated vaccinia virus LC16m8.
PLoS One. 2018 Feb 23;13(2):e0192725. doi: 10.1371/journal.pone.0192725. eCollection 2018.

本文引用的文献

1
Meeting of the Strategic Advisory Group of Experts on immunization, November 2013 -- conclusions and recommendations.
Wkly Epidemiol Rec. 2014 Jan 3;89(1):1-19.
2
Smallpox vaccine safety is dependent on T cells and not B cells.
J Infect Dis. 2011 Apr 15;203(8):1043-53. doi: 10.1093/infdis/jiq162.
3
A randomized, double-blind, dose-finding Phase II study to evaluate immunogenicity and safety of the third generation smallpox vaccine candidate IMVAMUNE.
Vaccine. 2010 Feb 3;28(5):1209-16. doi: 10.1016/j.vaccine.2009.11.030. Epub 2009 Nov 25.
4
Induction of natural killer cell responses by ectromelia virus controls infection.
J Virol. 2007 Apr;81(8):4070-9. doi: 10.1128/JVI.02061-06. Epub 2007 Feb 7.
5
LC16m8, a highly attenuated vaccinia virus vaccine lacking expression of the membrane protein B5R, protects monkeys from monkeypox.
J Virol. 2006 Jun;80(11):5179-88. doi: 10.1128/JVI.02642-05.
6
An attenuated LC16m8 smallpox vaccine: analysis of full-genome sequence and induction of immune protection.
J Virol. 2005 Sep;79(18):11873-91. doi: 10.1128/JVI.79.18.11873-11891.2005.
7
Genetically stable and fully effective smallpox vaccine strain constructed from highly attenuated vaccinia LC16m8.
Proc Natl Acad Sci U S A. 2005 Mar 15;102(11):4152-7. doi: 10.1073/pnas.0406671102. Epub 2005 Mar 7.
8
Biodefense. Smallpox vaccines: looking beyond the next generation.
Science. 2004 May 7;304(5672):809. doi: 10.1126/science.304.5672.809a.
9
Immunogenicity of a highly attenuated MVA smallpox vaccine and protection against monkeypox.
Nature. 2004 Mar 11;428(6979):182-5. doi: 10.1038/nature02331.
10
Myocarditis: the unexpected return of smallpox vaccine adverse events.
Lancet. 2003 Oct 25;362(9393):1345-6. doi: 10.1016/S0140-6736(03)14674-0.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验